{"data":{"id":"us-de/16-del.-c.-2604","jurisdiction":"us-de","citation":"16 Del. C. § 2604","heading":"Reimbursement by third-party payers.","body":"Blood lead testing, screening, screening-related services, and diagnostic evaluations as required by § 2602 of this title are reimbursable under health insurance contracts and group and blanket health insurance under §§ 3337 and 3554 of Title 18, respectively.","path":["Title 16. Health and Safety","Regulatory Provisions Concerning Public Health","CHAPTER 26. Childhood Lead Poisoning Prevention Act"],"source_url":"https://delcode.delaware.gov/title16/c026/index.html#2604","current_through":"2026-08-10 (85 Del. Laws, c. 421, 424)","vintage":"","retrieved_at":"2026-09-05T23:02:21Z","sha256":"2d07f04f8f93254e0881a4507221ee40d47665688421897f756097ac66e9ab34","source_id":"us-de","stale":true,"prev":"us-de/16-del.-c.-2603","next":"us-de/16-del.-c.-2605"},"notice":"GroundRules: Original legal text. Not legal advice."}